相关实验视频
Updated: May 29, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.4K
心力衰竭中的免疫细胞动态:涉及的机制和治疗点
Gen Li1,2, Wu He1,2, Dao Wen Wang1,2
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.
ESC heart failure
|February 5, 2025
概括
免疫激活显著影响心力衰竭 (HF) 的进展. 了解各种免疫细胞及其亚型的作用对于开发有针对性的疗法来更有效地治疗HF至关重要.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 炎症在心力衰竭 (HF) 中起着关键作用,影响心脏结构和功能.
- 尽管进行了研究,但导致高血压的确切免疫机制仍然不完全理解.
- 免疫细胞是细胞因子的关键来源,在HF进展中起着关键作用.
研究的目的:
- 提供不同免疫细胞类型和亚型在HF中的复杂作用的全面概述.
- 总结目前针对免疫细胞向的HF治疗的治疗目标和临床前证据.
- 确定未来的研究方向,以开发HF病原发生的精确干预措施.
主要方法:
- 关于心力衰竭中免疫激活研究的文献综述.
- 分析各种免疫细胞种群及其亚型的作用.
- 在HF模型中针对免疫细胞的实验证据的摘要.
主要成果:
- 免疫细胞的激活与心力衰竭的进展密切相关.
- 不同的免疫细胞子集对心脏功能和高频率的重塑产生不同的影响.
- 现有的抗炎疗法表现出有限的成功,突出了需要更深入的机制性见解.
结论:
- 彻底了解免疫细胞在HF阶段的参与是必不可少的.
- 准特定的免疫细胞和途径为新型HF疗法提供了潜力.
- 未来的研究应该专注于免疫细胞的相互关系,以准确的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Heart Failure Drugs: Inotropic Agents
505
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
505
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Pathophysiology of Cardiac Performance
513
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
513

